Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bone Marrow Edema Studied for Spondyloarthritis Diagnostic Insights

Catherine Kolonko  |  Issue: August 2018  |  August 17, 2018

“If you just focus on bone marrow edema and the range (of lesions) is between two and four, then the specificity is low and, you do not see erosion, then you have to be cautious,” says Dr. Weber. “This could be mechanical strain.”

First published in a 2009 article in the Annals of Rheumatic Diseases, the ASAS classification criteria for axial spondylo­arthritis define a positive MRI to diagnose sacroiliitis as one bone marrow edema lesion in two consecutive MRI slices or two or more bone marrow edema lesions on a single slice.2 The 97% specificity of the imaging arm of the ASAS axial spondyloarthritis classification criteria mistakenly led some rheumatologists to believe the sacroiliac joint changes on MRI, as defined by the criteria, could be used for diagnostic purposes in clinical practice, notes rheumatologist Atul Deodhar, MD, professor of medicine at Oregon Health & Science University, Portland, Ore.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The well-designed study by Dr. Weber and colleagues adds to the growing literature that shows low-grade bone marrow edema, fulfilling the ASAS definition, is seen in 25% of healthy individuals, plus in patients with nonspecific mechanical back pain, says Dr. Deodhar.

“We can draw two conclusions from this study,” says Dr. Deodhar. “First, classification criteria should not be used for making a diagnosis, and second, the definition of positive MRI of the SI joints for discrimination of early axSpA needs to be modified by a data-driven approach.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Weber advises rheumatologists to be cautious with the definition of active sacroiliitis when considering MRI results and to consider that isolated low-grade bone marrow edema may be insufficient to diagnose early axial spondyloarthritis. He also notes the disease is much more likely present if an MRI displays concomitant erosion and other structural lesions.


Catherine Kolonko is a medical writer based in Oregon.

References

  1. Weber U, Jurik AG, Zejden A, et al. Frequency and anatomic distribution of magnetic resonance imaging features in the sacroiliac joints of young athletes. Exploring ‘background noise toward a data‐driven definition of sacroiliitis in early spondyloarthritis. Arthritis Rheumatol. 2018 May;70(5):736–745.
  2. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009 Jun;68(6):777–783.

Page: 1 2 3 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditions Tagged with:bone marrow edema (BME)Magnetic resonance imaging (MRI)

Related Articles

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Imaging of Axial Psoriatic Arthritis

    May 9, 2022

    The axial phenotype of psoriatic arthritis (axPsA) is an excellent example of a major controversy in rheumatology that has become the focus of attention because of the emergence of new therapies with different mechanisms of action for alleviating joint inflammation. It was first described in 1961 but, until recently, it has largely remained under the…

    Imaging in Ankylosing Spondylitis

    April 1, 2015

    MRI inflammation, fat and new bone formation in the sacroiliac joints, spine in patients with AS

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences